BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rosati G, Ferrara D, Manzione L. New perspectives in the treatment of advanced or metastatic gastric cancer. World J Gastroenterol 2009; 15(22): 2689-2692 [PMID: 19522017 DOI: 10.3748/wjg.15.2689]
URL: https://www.wjgnet.com/1007-9327/full/v15/i22/2689.htm
Number Citing Articles
1
Wang Ma, Ming Gao, Wei He, Qingxia Fan. Oxaliplatin and teniposide can inhibit the proliferation and induce the apoptosis of gastric cancer cell line BGC-823 synergisticallyThe Chinese-German Journal of Clinical Oncology 2010; 9(3): 149 doi: 10.1007/s10330-009-0190-8
2
Károly Lapis. Gazdavédő peptidek és peptidomimetikumok, mint a rákterápia potenciális új eszközeiMagyar Onkológia 2010; 54(1): 47 doi: 10.1556/MOnkol.54.2010.1.7
3
Seung Tae Kim, Jeeyun Lee, Kyu Taek Lee, Jong Kyun Lee, Kwang Hyuk Lee, Seong-Ho Choi, Jin-Seok Heo, Dong Wook Choi, Se Hoon Park, Joon Oh Park, Ho Yeong Lim, Young Suk Park, Won Ki Kang. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of VaterMedical Oncology 2010; 27(4): 1149 doi: 10.1007/s12032-009-9351-4
4
Xiaowan Chen, Guoli Wang, Xiaoli Lu, Peng Gao, Yongxi Song, Jingxu Sun, Ailin Li, Yingying Xu, Huimian Xu, Zhenning Wang. Polymorphisms and haplotypes of the miR-148/152 family are associated with the risk and clinicopathological features of gastric cancer in a Northern Chinese populationMutagenesis 2014; 29(6): 401 doi: 10.1093/mutage/geu050
5
Jie Gao, Ningning Sai, Chengqin Wang, Xiehuang Sheng, Qianqian Shao, Chengjun Zhou, Yanqiu Shi, Shanzhen Sun, Xun Qu, Changjun Zhu. Overexpression of chromokinesin KIF4 inhibits proliferation of human gastric carcinoma cells both in vitro and in vivoTumor Biology 2011; 32(1): 53 doi: 10.1007/s13277-010-0090-0
6
Cong Wang, Dong-Jian Song, Zhi-Li Xu, Shu-Ping Xie, Jun-Hong Hu. A network meta-analysis of the short-term efficacy of five chemotherapy regimens based on cisplatin and fluorouracil for esophagogastric junctional adenocarcinomaExperimental & Molecular Medicine 2017; 49(9): e383 doi: 10.1038/emm.2017.170
7
Xuan Liu, Li-juan Xiu, Jian-peng Jiao, Jing Zhao, Ying Zhao, Ye Lu, Jun Shi, Yong-jin Li, Min Ye, Yu-fang Gu, Xiao-wei Wang, Jing-yu Xu, Ci-an Zhang, Yong-ying Liu, Yun Luo, Xiao-qiang Yue. Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: a retrospective clinical analysisJournal of Integrative Medicine 2017; 15(6): 469 doi: 10.1016/S2095-4964(17)60377-7
8
Jing-Han Li, Dan-Ying Zhang, Ji-Min Zhu, Ling Dong. Clinical applications and perspectives of circulating tumor DNA in gastric cancerCancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03209-4
9
Kai-Yuan Lin, Lu-Hai Wang, You-Cheng Hseu, Chia-Lang Fang, Hsin-Ling Yang, K.J. Senthil Kumar, Chein Tai, Yih-Huei Uen. Clinical Significance of Increased Guanine Nucleotide Exchange Factor Vav3 Expression in Human Gastric CancerMolecular Cancer Research 2012; 10(6): 750 doi: 10.1158/1541-7786.MCR-11-0598-T
10
Pawel Zayakin, Guntis Ancāns, Karīna Siliņa, Irēna Meistere, Zane Kalniņa, Diāna Andrejeva, Edgars Endzeliņš, Lāsma Ivanova, Angelina Pismennaja, Agnese Ruskule, Simona Doniņa, Thomas Wex, Peter Malfertheiner, Mārcis Leja, Aija Linē. Tumor‐associated autoantibody signature for the early detection of gastric cancerInternational Journal of Cancer 2013; 132(1): 137 doi: 10.1002/ijc.27667
11
Ning-ning Bian, Yong-hong Wang, Guang-tao Min. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysisInternational Journal of Surgery 2019; 62: 34 doi: 10.1016/j.ijsu.2018.11.010
12
S. Chen, Z. Zheng, J. Tang, X. Lin, X. Wang, J. Lin. Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese populationCarcinogenesis 2013; 34(5): 1018 doi: 10.1093/carcin/bgt010
13
Sudeep Karve, Maria Lorenzo, Astra M Liepa, Lisa M Hess, James A Kaye, Brian Calingaert. Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims DatabaseJournal of Gastric Cancer 2015; 15(2): 87 doi: 10.5230/jgc.2015.15.2.87
14
Minkyo Song, M. Constanza Camargo, Stephanie J. Weinstein, Ana F. Best, Satu Männistö, Demetrius Albanes, Charles S. Rabkin. Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western populationGastric Cancer 2018; 21(5): 729 doi: 10.1007/s10120-018-0807-0
15
Ch'angbum Rim, Jung-Ae Lee, Soojung Gong, Dong Wook Kang, Heebum Yang, Hyun Young Han, Nae Yu Kim. A Case of Long-Term Complete Remission of Advanced Gastric Adenocarcinoma with Liver MetastasisJournal of Gastric Cancer 2016; 16(2): 115 doi: 10.5230/jgc.2016.16.2.115
16
Shuaibing Wang, Jiejie Qin, Hua Ye, Keyan Wang, Jianxiang Shi, Yan Ma, Yitao Duan, Chunhua Song, Xiao Wang, Liping Dai, Kaijuan Wang, Peng Wang, Jianying Zhang. Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancerOncoImmunology 2018; : e1452582 doi: 10.1080/2162402X.2018.1452582
17
M. Song, M. C. Camargo, S. J. Weinstein, G. Murphy, N. D. Freedman, J. Koshiol, R. Z. Stolzenberg‐Solomon, C. C. Abnet, S. Männistö, D. Albanes, C. S. Rabkin. Serum pepsinogen 1 and anti‐Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish malesAlimentary Pharmacology & Therapeutics 2018; 47(4): 494 doi: 10.1111/apt.14471
18
Jing Zhang, Jiao Jiang, Xiaotian Wu. MATHEMATICAL SOLUTION OF A PHARMACOKINETIC MODEL WITH SIMULTANEOUS FIRST-ORDER AND HILL-TYPE ELIMINATIONJournal of Applied Analysis & Computation 2023; 13(2): 623 doi: 10.11948/20210365
19
Sávia Raquel Costa Normando, Pamela de Oliveira Delgado, Ana Katherine Soares Barbosa Rodrigues, Waldec Jorge David Filho, Fernando Luiz Affonso Fonseca, Felipe José Silva Melo Cruz, Auro del Giglio. Circulating free plasma tumor DNA in patients with advanced gastric cancer receiving systemic chemotherapyBMC Clinical Pathology 2018; 18(1) doi: 10.1186/s12907-018-0079-y
20
Hyun Woo Chung, Eun Jeong Lee, Yo-Han Cho, So Young Yoon, Young So, Sung-Yong Kim, Mark Hong Lee, Jeong Hwan Kim, Sun-Young Lee, In-Kyung Sung, Hyung-Seok Park, Moon-Won Yoo, Kyung-Yung Lee. High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinomaJournal of Cancer Research and Clinical Oncology 2010; 136(12): 1929 doi: 10.1007/s00432-010-0852-5
21
Zane Kalniņa, Irēna Meistere, Ilze Kikuste, Ivars Tolmanis, Pawel Zayakin, Aija Linē. Emerging blood-based biomarkers for detection of gastric cancerWorld Journal of Gastroenterology 2015; 21(41): 11636-11653 doi: 10.3748/wjg.v21.i41.11636
22
Nicholas A. Coupe, Deme Karikios, Shanley Chong, June Yap, Weng Ng, Neil Merrett, Michael Lin. Metabolic information on staging FDG-PET–CT as a prognostic tool in the evaluation of 97 patients with gastric cancerAnnals of Nuclear Medicine 2014; 28(2): 128 doi: 10.1007/s12149-013-0791-8
23
Dong-ta Zhong, Ri-ping Wu, Xin-li Wang, Xiao-bing Huang, Meng-xin Lin, Yan-qin Lan, Qiang Chen. Combination Chemotherapy with S-1 and Oxaliplatin (SOX) as First-Line Treatment in Elderly Patients with Advanced Gastric CancerPathology & Oncology Research 2015; 21(4): 867 doi: 10.1007/s12253-015-9903-1
24
Zhan-Dong Zhang, Ye Kong, Wei Yang, Bin Zhang, Yong-Lei Zhang, Er-Min Ma, Hong-Xing Liu, Xiao-Bin Chen, Ya-Wei Hua. Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancerWorld Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-115
25
LIJUN WANG, QUANMAO SONG, JINPENG LI, XIAOHUA CHEN. S-1 treatment leading to complete remission of advanced duodenal adenocarcinoma: A case reportMolecular and Clinical Oncology 2015; 3(5): 1184 doi: 10.3892/mco.2015.607
26
Tao Jiang, Hongjun Zhang, Xiguang Liu, Hao Song, Ruyong Yao, Jianbin Li, Yuanyuan Zhao. Effect of oxaliplatin combined with polyenephosphatidylcholine on the proliferation of human gastric cancer SGC-7901 cellsOncology Letters 2016; 12(6): 4538 doi: 10.3892/ol.2016.5293
27
Masahiko Nishiyama, Satoru Wada. Docetaxel: its role in current and future treatments for advanced gastric cancerGastric Cancer 2009; 12(3): 132 doi: 10.1007/s10120-009-0521-z
28
Rui Li, Lingyan Yuan, Jin Wang, Jiejun Wang. Co-expression of erythropoietin receptor with human epidermal growth factor 2 may counteract trastuzumab inhibition in gastric cancerMedical Hypotheses 2011; 77(6): 948 doi: 10.1016/j.mehy.2011.07.021
29
Song Liu, Ying Zhu, Lie‑Wen Lin, Shun‑Kai Ding, Xiao‑Cong Lin, Ke‑Li Zhong, Kai Pan, Yong Dai. The composition and variation of the BCR CDR3s in gastric cancerOncology Letters 2018;  doi: 10.3892/ol.2018.8677